CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

NCT06687772 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Thiotepa
DRUG: Carmustine
PROCEDURE: Autologous Stem Cell Transplant
DRUG: Anthracycline-based induction chemotherapy

Sponsor

Washington University School of Medicine